Special Interest Group in Vaccines


  1. To foster development and adoption of methods to improve the accurate and efficient collection of vaccine exposure information (e.g., 2D barcodes, vaccine generic names, vaccine doses and dates of delivery) for each vaccinee.  Lot identifiers, in particular, would allow verification of the exact vaccine product (type and manufacturer) as well as linkage to details of vaccine antigens, preservatives, and excipients).
  2. To foster development and sharing of new/existing methods for vaccine safety, effectiveness, usage, cost-benefit, risk-management/mitigation across the life cycle of vaccines from pre- to post-licensure, and from signal detection to hypothesis testing.
  3. To provide a forum for interaction with regulatory authorities and public health agencies to raise awareness and stimulate incorporation of vaccine specific and relevant aspects into regulations and regulatory templates.
  4. To assist low and middle-income countries with development of their data collection and technical expertise in vaccine pharmacoepidemiology.


The SIG strives to achieve these goals by offering a platform for interested ISPE members to plan educational activities for the ICPE pre-conference courses together with the education committee, shared national and international projects and grant proposals, and joined presentation in form of workshops, symposia or poster walks at annual ICPE meetings. Whenever possible, the VAX SIG will seek to maximize synergy with existing vaccine institutions and stakeholders.

SIG homepage on ISPE Exchange (login required)

SIG leader(s)

Chair Catherine Panozzo, PhD, MPH Department of Population Medicine
Harvard Pilgrim Health Care Institute/Harvard Medical School
Vice-Chair Bradley Layton RTI Health Solutions
Secretary Jen Gerber RTI Health Solutions

Workgroup Leaders

Regulatory Guidance Mendel Haag, PhD Epidemiology
Amsterdam, Netherlands
Methodology Patricia Saddier, MD, PhD Pharmacoepidemiology Department
Merck Research Laboratories
Pennsylvania, USA
Education and Advocacy in Low and Middle Income Countries Andrea Sutherland, MD Merck
Rockville, Maryland, USA
Education and Advocacy in Low and Middle Income Countries Daniel Weibel, PhD Erasmus University Medical Center
Rotterdam, Netherland


Victoria Abbing

Penina Haber Piku Patnaik

Syed Ahmad

Francois Haguinet Vitali Pool

Kandace Amend

Eelko Hak Nicolas Praet

Valentina Attanasi

Janet Hardy Natalia Ramos-Hernandez

Steven Bailey

Susanne Hartwig Patricia Saddier

Meghan Baker

Kui Huang Nehemiah Samson

Sonja Banga

Wei-I Huang Daphne Sawlwin

Vincent Bauchau

Wan-Ting Huang Harry Seifert

Jorgen Bauwens

Kwan Hur Vivek Shinde

Alex Bica

Judith Jones Francois Simondon

Kaat Bollaerts

Sun-Young Jung James Stark

Didier Nzolo Boolene

Dan Kajungu Miriam Sturkenboom

Elliott Bosco

Alison Kawai Andrea Sutherland

Bob Brody

Alena Khromava Charlotte Switzer

Anne Butler

Nicky Klein Carla Talarico

Bing Cai

Sonali Kochhar Kyrstie Thai

Rebecca Chandler

Carol Koro Lina Titievsky

Bob Chen

Martin Kuldorff Sylvie Tomczyk

Jing Chen

Tamar Lasky Thomas Verstraeten

Catherine Cohet

Bradley Layton Silvia Perez Vilar

Adam Cui

Hankil Lee Alec Walker

Caitlin Dodd

Andreia Leite Wei Wang

Gael Dos Santos

Se Li Chengbin Wang

Jonathan Duffy

Yun Lu Daniel Weibel

Katherine Duszynski

Olivia Mahaux Lisa Weiss

Emmanuelle Espie

Morgan Marks Yonas Weldeselassie

Deshayne Fell

Robert Maroko Heather Whitaker

Germano Ferreira

Josiah Masuka Corinne Willame

Bruce Fireman

Mike McNeil Jerome Wilson

Vera Frajzyngier

Alexandru Mihai Bica Bob Wise

Lourdes Frau

Sharareh Modaressi Katherine Yih

Jen Gerber

Pedro Moro Xue Dan You

Julia Glanternik

Gui Jun Ning Yinong Young-Xu

Kristin Goddard

Josephine Ocran-Appiah Mitra Yousefi

Joanne Gruber

Yvonne Ohadike Huifeng Yun

Mendel Haag

Catherine Panozzo Qusseny Zerbo

Dates of Meetings

Occurs the first Wednesday of every month at 9:00 am EST (UTC/GMT -5 hours). Interested persons should email Catherine Panozzo:

Meeting Minutes